Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.
Oncogene, ISSN: 09509232 14765594
|
Cancer Discovery, ISSN: 21598274 21598290
|
Cancer Discovery, ISSN: 21598274 21598290
|
Journal of Neuroscience, ISSN: 02706474 15292401
|
Biophysical Journal, ISSN: 00063495 15420086
|
Proceedings of the National Academy of Sciences of the United States of America, ISSN: 00278424 10916490
|
Autoimmunity, ISSN: 08916934 1607842X
|
Genome Biology, ISSN: 1474760X 14747596
|
Journal of Biological Chemistry, ISSN: 00219258 1083351X
|
Cell Cycle, ISSN: 15514005 15384101
|
Rapid Communications in Mass Spectrometry, ISSN: 09514198 10970231
|
Clinical Cancer Research, ISSN: 10780432 15573265
|
Journal of Biological Chemistry, ISSN: 00219258 1083351X
|
ACS Chemical Biology, ISSN: 15548937 15548929
|
Blood, ISSN: 15280020 00064971
|
Nature, ISSN: 00280836 14764687
|
Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges,
|
Journal of Biological Chemistry, ISSN: 00219258 1083351X
|
Journal of Leukocyte Biology, ISSN: 07415400 19383673
|
Blood, ISSN: 15280020 00064971
|
PLoS ONE, ISSN: 19326203
|
Science Translational Medicine, ISSN: 19466234 19466242
|
Journal of the American Chemical Society, ISSN: 15205126 00027863
|
PLoS ONE, ISSN: 19326203
|
Molecular Pharmaceutics, ISSN: 15438384 15438392
|
PLoS Genetics, ISSN: 15537390 15537404
|
Clinical Pharmacology and Therapeutics, ISSN: 00099236 15326535
|
PLoS Genetics, ISSN: 15537390 15537404
|
Breast Cancer Research and Treatment, ISSN: 15737217 01676806
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
Bioorganic and Medicinal Chemistry Letters, ISSN: 0960894X 14643405
|
Clinical Cancer Research, ISSN: 10780432 15573265
|
Bioorganic and Medicinal Chemistry Letters, ISSN: 0960894X 14643405
|
Journal of Pharmacology and Experimental Therapeutics, ISSN: 00223565 15210103
|
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Nature Medicine, ISSN: 10788956 1546170X
|
Journal of Pharmacology and Experimental Therapeutics, ISSN: 00223565 15210103
|
Nature Immunology, ISSN: 15292908 15292916
|
Clinical Trials, ISSN: 17407745 17407753
|
Arthritis Care and Research, ISSN: 2151464X 21514658
|
Toxicologic Pathology, ISSN: 01926233 15331601
|
Xenobiotica, ISSN: 00498254 13665928
|
Regulatory Toxicology and Pharmacology, ISSN: 02732300 10960295
|
Expert Opinion on Therapeutic Patents, ISSN: 13543776 17447674
|
Journal of Cancer Research and Clinical Oncology, ISSN: 01715216 14321335
|
Nature Genetics, ISSN: 10614036 15461718
|
Drug Metabolism and Disposition, ISSN: 00909556 1521009X
|
Alimentary Pharmacology and Therapeutics, ISSN: 02692813 13652036
|
Journal of Immunological Methods, ISSN: 00221759 18727905
|
Cell Reports, ISSN: 22111247
|
PLoS ONE, ISSN: 19326203
|